Table 3.
Reference | Number of patients | Follow-up (months) | Facial nerve preservation (%) | Cochlear nerve preservation (%) | Tumor control (%) |
---|---|---|---|---|---|
Iwai et al. [27] | 14 | 32 | 85.7 | NA | 79 |
Park et al. [50] | 8 | 68.8 | NA | NA | 100 |
Yang et al. [78] | 61 | 53.7 | 95 | NA | 93.5 |
Fuentes et al. [15] | 8 | 46 | 87.5 | NA | 100 |
Van de Langenberg et al. [69] | 50 | 33.8 | 94 | 25 (1/4) | 90 |
Pan et al. [49] | 18 | 57 | 89 | 100 (11/11) | 100 |
Iwai et al. [28] | 40 | 66 | 95 | 42.9 (6/14) | 90 |
Radwan et al. [53] | 22 | 28 | 87 | NA | 100 |
Present study | 32 | 29 | 100 | 76.9 (10/13) | 91.6 |